Exploration of Medicine

Table 1

Distribution of CC Moroccan patients according to clinicopathological characteristics (n = 80)

Characteristics	Type	Sample number (n)	Percentage (%)
Age at diagnosis (year, mean age = 54)	27–41	15	18.8
	42–61	45	56.3
	> 61	20	25.0
FIGO clinical stage	I	16	20.0
	II	57	71.3
	III	7	8.8
	IV	0	–
Histological type	SCC	66	82.5
Histological type	Adenocarcinoma	14	17.5
Age at menarche (in years)	≤ 12	55	68.8
Age at menarche (in years)	> 12	25	31.3
Menopause	Yes	54	67.5
Menopause	No	26	32.5
Age at menopause (in years)	< 45	14	25.9
Age at menopause (in years)	≥ 45	40	74.1
Oral contraceptives use	Yes	56	70
Oral contraceptives use	No	24	30
Duration of oral contraceptives use (in years)	≥ 5	33	58.9
Duration of oral contraceptives use (in years)	< 5	23	41.1
ABO blood group	A+	17	21.25
	A–	5	6.25
	B+	11	13.75
	B–	7	8.75
	AB+	2	2.50
	AB–	0	–
	O+	32	40.00
	O–	6	7.50
Parity	Yes	70	87.5
Parity	No	10	12.5
Number of children	1–2	30	42.9
Number of children	≥ 3	40	57.1
Childbirth delivery	Vaginal birth	59	84.3
Childbirth delivery	Caesarean section	11	15.7
Residence area	Urban and sub-urban	58	72.5
Residence area	Rural	22	27.5
Marital status	Single (separated or widowed)	18	22.5
Marital status	Married	62	77.5
Health insurance	Covered (RAMED)	75	93.8
Health insurance	Not covered	5	6.3

FIGO: International Federation of Gynecology and Obstetrics; –: not applicable; RAMED: Regime d’Assistance Medicale